Compounded semaglutide
Sold by Kin Meds · every compounded semaglutide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$348
| Medication · Personalized GLP-1, all doses | $199 |
|---|---|
| Required membership | $149 |
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Personalized GLP-1, all doses “Personalized GLP-1 All Doses just $199 * Same Price. Every Dose .” source, read September 2, 2026 | Per month$199 | Charged today$199 |
We earn nothing from this link. Kin Meds has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
- September 2, 2026 — $199
- September 3, 2026 — $199
- September 2, 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | Rush Pharmacy; Strive Pharmacy |
|---|---|
| Cancellation | “You can always login to your kinmeds.com account before your products ship to change your address, method of payment or to cancel your subscription.” |
| Membership | Required. $149 per month. “Kin Med's Membership Fee $149 /mo” |
Not yet checked: states, prescriber and consult fee.
Recorded from kinmeds.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — The branded-medications page is a near-exact match for the brief's membership-trap example: each drug card ('Wegovy® Injection', 'Wegovy® Pill', 'Zepbound®', 'Foundayo®', 'Zepbound® Vial') shows 'Starting at $149' with a footnote '* $149 for the provider consultation and follow ups only. Price of the medication(s) are charged upon consult approval.' The comparison table separately shows 'Kin Med's Membership Fee $149/mo' AND 'Prescription Medication (Paid Only if Approved) From $149/mo' as two distinct line items that happen to share the same number -- both were recorded but are NOT the same charge. The 'Personalized GLP-1' ($199) vs 'Personalized GLP-1/GIP+B12' ($249) compounded product classification into semaglutide vs tirzepatide is inferred from page naming (GIP dual-agonist mechanism = tirzepatide), since the site's own footer disclaimer says formulations may contain 'Semaglutide or Tirzepatide' determined by the prescribing provider -- treat the semaglutide/tirzepatide split with some caution.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.